Suzanne Brignoli

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Data generated using various immunoassay methods are an integral part of the development of protein therapeutics. These assays are used in clinical and preclinical studies to establish the pharmacokinetic (PK) and pharmacodynamic (PD) characteristics as well as to assess the immunogenicity properties of a therapeutic. PK assays measure therapeutic levels(More)
  • 1